332TiP SOLTI-1907 ATREZZO: Targeting hormonal receptor negative (HR-) or PAM50 non-luminal disease with atezolizumab in combination with trastuzumab and vinorelbine in HER2+ metastatic breast cancer (MBC)

Autor:	Antonia Perelló, Sonia Servitja, J. Ponce Lorenzo, Eva Ciruelos, P. Tolosa, Juan M Ferrero-Cafiero, J.M. Cejalvo, Juan Antonio Guerra, F.J. Salvador Bofill, Isabel Blancas, C. Albacar, Santiago Escrivá-de-Romaní, Sonia Pernas, Josefina Cruz, Cristina Rodríguez, Martínez Pérez, Esther Sanfeliu, Aurelio López, Santiago González-Santiago, Aleix Prat
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty business.industry Hematology Disease Vinorelbine medicine.disease Metastatic breast cancer Atezolizumab Trastuzumab Internal medicine medicine business Receptor medicine.drug Hormone
Zdroj:	Annals of Oncology. 32:S511
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.615
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e79724cde2ed3b2d20c8f7208aa738df https://doi.org/10.1016/j.annonc.2021.08.615 Zobrazit plný text záznamu